Apellis Pharmaceuticals Inc (APLS)
33.18
+0.04
(+0.11%)
USD |
NASDAQ |
Dec 20, 16:00
33.18
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Profit Margin (Quarterly): -29.19% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 15.76% |
| Biomarin Pharmaceutical Inc | 14.22% |
| Ionis Pharmaceuticals Inc | -105.0% |
| QuidelOrtho Corp | -2.74% |
| Moderna Inc | 0.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -104.7% |
| Return on Assets | -29.46% |
| Return on Invested Capital | -52.47% |
| Gross Profit Margin (Quarterly) | 82.95% |
| Operating Margin (Quarterly) | -24.02% |
| Return on Net Operating Assets | -55.90% |